CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
301408 Anhui Huaren Health Pharmaceutical
- 11.47
- +0.20+1.77%
Market Closed Apr 30 15:00 CST
4.59BMarket Cap30.34P/E (TTM)
11.70High11.26Low69.45KlotVolume11.27Open11.27Pre Close79.66MTurnover4.66%Turnover Ratio33.34P/E (Static)400.01MShares14.5052wk High2.22P/B1.71BFloat Cap9.3052wk Low13.52Limit Up149.17MShs Float28.40Historical High9.02Limit Down3.90%Amplitude9.30Historical Low0.10Dividend TTM11.47Avg Price32.73KlotAsk0.87%Div YieldTTM100Lot Size34.93KlotBid
Anhui Huaren Health Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 14.71%1.27B | 19.34%4.53B | 22.07%3.27B | 25.21%2.17B | 30.60%1.1B | 16.39%3.8B | 19.71%2.68B | 22.80%1.73B | 24.91%845.61M | 39.50%3.26B |
| Operating revenue | 14.71%1.27B | 19.34%4.53B | 22.07%3.27B | 25.21%2.17B | 30.60%1.1B | 16.39%3.8B | 19.71%2.68B | 22.80%1.73B | 24.91%845.61M | 39.50%3.26B |
| Other operating revenue | ---- | 4.55%77.81M | ---- | 2.26%34.32M | ---- | 22.53%74.42M | ---- | 5.17%33.56M | ---- | -12.55%60.74M |
| Interest income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Commission income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | --0 |
| Premiums earned | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | --0 |
| Total operating cost | 13.80%1.18B | 18.23%4.32B | 21.78%3.13B | 24.74%2.07B | 28.08%1.03B | 19.81%3.66B | 19.82%2.57B | 22.73%1.66B | 23.37%806.31M | 35.71%3.05B |
| Operating cost | 13.47%841.49M | 15.94%3.05B | 20.55%2.21B | 24.50%1.48B | 29.96%741.62M | 19.73%2.63B | 19.52%1.83B | 24.10%1.19B | 25.35%570.67M | 44.41%2.2B |
| Operating tax surcharges | 1.95%5.08M | 42.07%23.75M | 47.99%15.61M | 65.13%10.23M | 61.59%4.98M | -2.91%16.72M | -4.84%10.55M | -12.15%6.19M | -8.98%3.08M | 31.20%17.22M |
| Operating expense | 13.87%261.3M | 24.03%997.77M | 22.89%728.53M | 22.83%467.5M | 23.53%229.48M | 22.18%804.47M | 26.46%592.82M | 24.33%380.61M | 21.20%185.76M | 18.29%658.43M |
| Administration expense | 23.69%56.33M | 22.64%194.39M | 22.94%141.17M | 21.53%92.5M | 13.76%45.54M | 5.59%158.51M | 0.42%114.83M | 5.33%76.12M | 13.34%40.03M | 14.20%150.12M |
| Financial expense | -8.40%4.49M | 27.62%24.69M | 31.99%17.91M | 26.36%10.13M | 3.56%4.9M | -14.76%19.35M | -23.75%13.57M | -33.15%8.01M | -21.97%4.73M | -6.06%22.7M |
| -Interest expense (Financial expense) | -15.35%3.59M | 18.58%14.52M | 84.71%12.99M | 54.40%6.47M | 77.74%4.25M | 77.65%12.24M | 97.86%7.03M | 31.83%4.19M | 193.93%2.39M | 43.59%6.89M |
| -Interest Income (Financial expense) | 20.94%-3.66M | -10.60%-15.56M | -40.98%-11.11M | -38.58%-8.9M | -80.81%-4.63M | -228.38%-14.07M | -247.52%-7.88M | -398.53%-6.42M | -2,126.32%-2.56M | -121.21%-4.28M |
| Research and development | 5.26%6.52M | 21.46%29.39M | 138.46%21.1M | 255.75%15.4M | 205.62%6.2M | 480.42%24.19M | 286.64%8.85M | 729.43%4.33M | 705.83%2.03M | 735.76%4.17M |
| Credit Impairment Loss | 42.68%-2.79M | 78.19%-1M | -56.15%-4.08M | 31.42%-1.97M | -142.05%-4.87M | 36.21%-4.59M | 52.59%-2.61M | 26.73%-2.87M | 5.52%-2.01M | -42.79%-7.19M |
| Asset Impairment Loss | -427.89%-8.48M | -300.45%-27.49M | -41.51%-5.24M | -24.49%-4.81M | -271.73%-1.61M | -64.00%-6.86M | -10.99%-3.7M | 3.50%-3.86M | 44.62%-432.15K | -85.42%-4.19M |
| Other net revenue | -223.13%-7.26M | -101.43%-178.85K | 1.90%13.57M | -3.64%7.92M | -133.66%-2.25M | 379.50%12.54M | 932.36%13.32M | 1,911.79%8.22M | -258.97%-961.32K | -12.15%2.62M |
| Fair value change income | ---- | --0 | -98.80%387.7 | --0 | --13.77K | --33.95K | --32.43K | --0 | --0 | --0 |
| Invest income | 41.35%348.8K | 110.14%1.62M | 196.05%1.25M | 286.14%634.98K | 1,062.69%246.76K | -5.01%770.34K | 9.29%422.67K | -19.54%164.44K | -11.92%21.22K | -2.37%810.96K |
| Net open hedge income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | --0 |
| -Including: Investment income associates | ---- | 15.91%183.43K | ---- | --0 | ---- | --158.26K | ---- | --0 | --0 | --0 |
| Exchange income | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 |
| Asset deal income | 43.62%915.25K | 160.17%2.72M | 641.41%2.07M | 550.83%831.07K | 1,473.56%637.29K | 71.11%1.04M | -50.52%279.62K | -75.63%127.69K | -74.63%40.5K | 222.81%610.61K |
| Other revenue | -17.47%2.75M | 8.25%23.97M | 3.53%19.57M | -9.74%13.23M | 134.50%3.33M | 76.12%22.14M | 105.76%18.9M | 92.90%14.66M | -57.36%1.42M | 35.89%12.57M |
| Operating profit | 21.59%84.38M | 36.14%207.92M | 26.06%149.1M | 32.22%102.73M | 81.00%69.4M | -28.21%152.72M | 29.99%118.28M | 38.22%77.7M | 59.66%38.34M | 129.86%212.72M |
| Add:Non operating Income | 40.99%223.39K | 343.73%1.02M | 318.74%879.75K | 106.99%340.8K | -6.59%158.44K | -92.55%230.37K | -93.23%210.1K | -94.44%164.64K | 121.70%169.61K | 3.85%3.09M |
| Less:Non operating expense | 179.37%1.05M | 140.40%3.48M | 219.76%1.77M | 273.60%1.01M | 191.89%375.95K | 34.52%1.45M | -46.41%552.15K | -58.22%269.08K | -70.37%128.8K | -17.89%1.07M |
| Total profit | 20.78%83.56M | 35.62%205.47M | 25.67%148.22M | 31.55%102.07M | 80.25%69.18M | -29.45%151.51M | 26.72%117.94M | 32.58%77.59M | 62.25%38.38M | 127.93%214.74M |
| Less:Income tax cost | 10.73%18.47M | 57.31%53.21M | 10.38%32.35M | 13.61%22.25M | 80.85%16.68M | -37.92%33.83M | 16.99%29.31M | 19.15%19.59M | 11.64%9.23M | 122.54%54.48M |
| Net profit | 23.97%65.08M | 29.38%152.26M | 30.73%115.87M | 37.60%79.81M | 80.05%52.5M | -26.57%117.68M | 30.31%88.63M | 37.82%58M | 89.42%29.16M | 129.82%160.26M |
| Net profit from continuing operation | 23.97%65.08M | 29.38%152.26M | 30.73%115.87M | 37.60%79.81M | 80.05%52.5M | -26.57%117.68M | 30.31%88.63M | 37.82%58M | 89.42%29.16M | 129.82%160.26M |
| Net income from discontinuing operating | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| Less:Minority Profit | -18.32%3.86M | 382.95%14.56M | 1,192.43%7.94M | 2,951.10%6.84M | 1,553.63%4.73M | 682.12%3.01M | 305.21%614.09K | -123.85%-240.04K | -580.25%-325.26K | -8,817.66%-517.88K |
| Net profit of parent company owners | 28.15%61.22M | 20.09%137.7M | 22.62%107.93M | 25.29%72.97M | 62.03%47.77M | -28.68%114.67M | 28.84%88.02M | 38.04%58.24M | 90.94%29.48M | 130.58%160.78M |
| Earning per share | ||||||||||
| Basic earning per share | 28.22%0.1531 | 17.24%0.34 | 18.54%0.2698 | 18.98%0.1824 | 45.79%0.1194 | -38.30%0.29 | 13.29%0.2276 | 23.53%0.1533 | 80.40%0.0819 | 123.81%0.47 |
| Diluted earning per share | 28.22%0.1531 | 17.24%0.34 | 18.54%0.2698 | 18.98%0.1824 | 45.79%0.1194 | -38.30%0.29 | 13.29%0.2276 | 23.53%0.1533 | 80.40%0.0819 | 123.81%0.47 |
| Other composite income | -84.34%334.33K | -85.91%300.9K | 2.13M | 2.13M | 2.13M | 0 | 0 | |||
| Other composite income of parent company owners | ---- | -84.34%334.33K | -85.91%300.9K | ---- | ---- | --2.13M | --2.13M | --2.13M | --0 | ---- |
| Other composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Total composite income | 23.97%65.08M | 27.36%152.59M | 27.99%116.17M | 32.72%79.81M | 80.05%52.5M | -25.23%119.82M | 33.45%90.77M | 42.89%60.14M | 89.42%29.16M | 129.82%160.26M |
| Total composite income of parent company owners | 28.15%61.22M | 18.18%138.03M | 20.05%108.23M | 20.86%72.97M | 62.03%47.77M | -27.35%116.8M | 31.97%90.15M | 43.10%60.38M | 90.94%29.48M | 130.58%160.78M |
| Total composite income of minority owners | -18.32%3.86M | 382.95%14.56M | 1,192.43%7.94M | 2,951.10%6.84M | 1,553.63%4.73M | 682.12%3.01M | 305.21%614.09K | -123.85%-240.04K | -580.25%-325.26K | -8,817.66%-517.88K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.